Janelle Manton, MD
Dermatology · Glastonbury, CTNPI 1841267986
Payments from drug & device makers
Across 337 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- E.r. Squibb & Sons, L.L.C.$614
- LEO Pharma Inc.$333
- Galderma Laboratories, L.p.$316
- Dermavant Sciences, Inc.$301
- Pfizer$271
- plus $2K from 24 others
What the payments were for
- Food & beverage$6,535100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 149 | $2,675 |
| E.r. Squibb & Sons, L.L.C. | 38 | $614 |
| LEO Pharma Inc. | 21 | $333 |
| Galderma Laboratories, L.p. | 11 | $316 |
| Dermavant Sciences, Inc. | 14 | $301 |
| Pfizer | 15 | $271 |
| UCB, Inc. | 9 | $221 |
| Regeneron Healthcare Solutions, Inc. | 9 | $217 |
| Sun Pharmaceutical Industries Inc. | 8 | $206 |
| Novartis | 12 | $201 |
| Incyte Corporation | 6 | $152 |
| Lilly USA, LLC | 6 | $148 |
| Johnson & Johnson | 5 | $133 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $120 |
| Botanix SB Inc | 4 | $97 |
| Amgen | 3 | $71 |
| Boehringer Ingelheim | 3 | $70 |
| Mayne Pharma Commercial LLC | 3 | $64 |
| Almirall LLC | 3 | $60 |
| Sanofi | 2 | $52 |
| Merz North America, Inc. | 1 | $41 |
| EPI Health, LLC | 1 | $30 |
| LNHC, Inc | 1 | $21 |
| Organon | 1 | $21 |
| Genentech USA, Inc. | 1 | $19 |
| Dermira, Inc. | 1 | $18 |
| Biofrontera Inc. | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Merck | 1 | $13 |
How this compares
$6,535 in reported general payments places this provider in the 60th percentile of 222 dermatology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $88,550 |
| Fluorouracil | 71 | $4,066 |
| Ketoconazole | 206 | $3,450 |
| Pimecrolimus | 13 | $3,183 |
| Clobetasol Propionate | 58 | $3,001 |
| Metronidazole | 33 | $2,547 |
| Tretinoin | 22 | $1,508 |
| ValacyclovirValacyclovir Hcl | 36 | $975 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 26 | $934 |
| Ciclopirox | 27 | $736 |
| CiclopiroxCiclopirox Olamine | 28 | $601 |
| Betamethasone Dipropionate | 18 | $573 |
| Doxycycline Hyclate | 17 | $439 |
| Triamcinolone Acetonide | 79 | $432 |
| Azelaic Acid | 17 | $306 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Glastonbury
- Ali BankiGlastonbury$12K
- Brett KingFairfield$6.1M
- Michael PayetteCromwell$3.4M
- Bruce StroberCromwell$3.3M
- Lisa DonofrioNew Haven$2.3M
- Mona ShahriariCromwell$2.3M
- Jeremy MossMadison$2.2M
- Brittany CraiglowFairfield$1.9M
- Meagen McCuskerEnfield$1.8M
- Christopher BunickNew Haven$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.